{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-23-012952","form_type":"8-K","ticker":null,"cik":"0001044378","company_name":"BIOCEPT INC","filed_at":"2023-10-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.010869+00:00","generated_at":"2026-06-09T23:03:38.663903+00:00","sec_items":["1.03","5.02"],"event_type":"other_material","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Biocept files Chapter 7 bankruptcy, board and CEO resign","bullets":["Filed voluntary Chapter 7 petition on October 13, 2023 in Delaware Bankruptcy Court.","A Chapter 7 trustee will liquidate assets and pay claims per the Bankruptcy Code.","Entire board (Antonino Morales, Marsha Chandler, Bruce Gerhardt, Quyen Dao-Haddock, Ivor Royston, Linda Rubinstein) resigned effective Oct 13.","CEO Antonino Morales also resigned as President and CEO effective Oct 13.","Resignations not due to disagreements but due to the bankruptcy filing eliminating board powers."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-23-012952","json":"https://secwatch.observer/filing/0001654954-23-012952.json","markdown":"https://secwatch.observer/filing/0001654954-23-012952.md","text":"https://secwatch.observer/filing/0001654954-23-012952.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1044378/000165495423012952/0001654954-23-012952-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1044378/000165495423012952/biocept_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T23:03:38.663903+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f6456f9f99eea5c0b9f0fb0664c14076face9b0b","claim":"BIOCEPT INC entered chapter 7 in United States Bankruptcy Court for the District of Delaware (petition 2023-10-13).","evidence_excerpt":"Biocept, Inc., a Delaware corporation (the “Company”), filed a voluntary petition for relief (the “Petition”) under the provisions of Chapter 7 of Title 11 of the United States Code, 11 U.S.C. §§ 101 et seq. (the “Code”) in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) on October 13, 2023.","evidence_source":"SEC 8-K Item 1.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1044378/000165495423012952/0001654954-23-012952-index.htm","confidence":0.9,"family_label":"Distress & Bankruptcy","details":[{"label":"Proceeding","value":"chapter 7"},{"label":"Court","value":"United States Bankruptcy Court for the District of Delaware"},{"label":"Petition","value":"2023-10-13"}],"fact_type":"distress_event"},{"claim_id":"14a59ca806","claim":"Ivor Royston resigned as Director at BIOCEPT INC.","evidence_excerpt":"Antonino Morales, Marsha A. Chandler, Bruce E. Gerhardt, Quyen Dao-Haddock, Ivor Royston, and Linda Rubinstein (each a \"Member\" and collectively the \"Members\") tendered their resignations as members of the Company's Board of Directors which resignations were effective on October 13, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1044378/000165495423012952/0001654954-23-012952-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"1822715ad8","claim":"Antonino Morales resigned as President and Chief Executive Officer at BIOCEPT INC.","evidence_excerpt":"In addition to his resignation from the Company's Board of Directors, Mr. Morales tendered his resignation as the Company's President and Chief Executive Officer effective on October 13, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1044378/000165495423012952/0001654954-23-012952-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"4a2bba8ede","claim":"Linda Rubinstein resigned as Director at BIOCEPT INC.","evidence_excerpt":"Antonino Morales, Marsha A. Chandler, Bruce E. Gerhardt, Quyen Dao-Haddock, Ivor Royston, and Linda Rubinstein (each a \"Member\" and collectively the \"Members\") tendered their resignations as members of the Company's Board of Directors which resignations were effective on October 13, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1044378/000165495423012952/0001654954-23-012952-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"59d4b3d28d","claim":"Quyen Dao-Haddock resigned as Director at BIOCEPT INC.","evidence_excerpt":"Antonino Morales, Marsha A. Chandler, Bruce E. Gerhardt, Quyen Dao-Haddock, Ivor Royston, and Linda Rubinstein (each a \"Member\" and collectively the \"Members\") tendered their resignations as members of the Company's Board of Directors which resignations were effective on October 13, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1044378/000165495423012952/0001654954-23-012952-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"795ddcf030","claim":"Antonino Morales resigned as Director at BIOCEPT INC.","evidence_excerpt":"Antonino Morales, Marsha A. Chandler, Bruce E. Gerhardt, Quyen Dao-Haddock, Ivor Royston, and Linda Rubinstein (each a \"Member\" and collectively the \"Members\") tendered their resignations as members of the Company's Board of Directors which resignations were effective on October 13, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1044378/000165495423012952/0001654954-23-012952-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b1f01cdbfa","claim":"Bruce E. Gerhardt resigned as Director at BIOCEPT INC.","evidence_excerpt":"Antonino Morales, Marsha A. Chandler, Bruce E. Gerhardt, Quyen Dao-Haddock, Ivor Royston, and Linda Rubinstein (each a \"Member\" and collectively the \"Members\") tendered their resignations as members of the Company's Board of Directors which resignations were effective on October 13, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1044378/000165495423012952/0001654954-23-012952-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"bdee670639","claim":"Marsha A. Chandler resigned as Director at BIOCEPT INC.","evidence_excerpt":"Antonino Morales, Marsha A. Chandler, Bruce E. Gerhardt, Quyen Dao-Haddock, Ivor Royston, and Linda Rubinstein (each a \"Member\" and collectively the \"Members\") tendered their resignations as members of the Company's Board of Directors which resignations were effective on October 13, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1044378/000165495423012952/0001654954-23-012952-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}